logo
Officials warn the next opioid epidemic could come from substance sold at vape shops for less $10

Officials warn the next opioid epidemic could come from substance sold at vape shops for less $10

Daily Mail​2 days ago
Public health experts and officials have trained their sights on a new vape shop staple they fear could spur the next wave of the opioid epidemic.
Department of Health and Human Services made a formal proposal to the DEA to classify 7-OH, a component of the pain reliever kratom, as a Schedule 1 substance, alongside heroin, LSD, and other drugs with no accepted medical use.
While natural kratom contains only trace amounts of 7-OH, manufacturers have begun chemically isolating and concentrating it into a synthetic opioid-like drug estimated to be 10 to 13 times more potent than morphine.
These ultra-potent extracts, often sold as gummies, shots and pills, now flood gas stations and vape shops with spotty age restrictions.
FDA Commissioner Dr Marty Makary said: 'Vape stores are popping up in every neighborhood in America, and many are selling addictive products like concentrated 7-OH. After the last wave of the opioid epidemic, we cannot get caught flat-footed again.'
The FDA's move was quickly followed by the Florida state attorney general James Uthmeier's decision to ban selling, having, or sharing 7-OH altogether, citing an 'immediate danger to the public health, safety and welfare.'
The announcement makes Florida the first state to ban products containing 7-OH, which could set off a nationwide domino effect with more and more states following suit.
7-OH is a relative newcomer, and data on deaths are not well documented, but poison control center reports suggest it is growing rapidly more popular. The Pennsylvania Department of Health issued a warning earlier this month about it, noting 'increased call volume around both kratom and 7-OH consumption.'
Pressed about 7-OH overdose risks, Makary cited scarce data and doctors' inability to identify it, while still calling the compound a 'killer,' far deadlier than plain kratom.
The federal government has not tracked any deaths due to 7-OH specifically, though at least one has occurred.
Matthew Torres, a 39-year-old Oregon carpenter, died from violent seizures in May 2021 after using kratom to manage chronic pain. His girlfriend found him foaming at the mouth at their Beavercreek home. The coroner ruled his death was caused by 'toxic effects of mitragynine (7-OH).'
His mother Mary Torres is now pursuing a $10M wrongful death lawsuit against the smoke shop that sold it, alleging they failed to warn about risks.
Jordan McKibban, 37, died in 2022 after consuming kratom powder purchased from an organic store, believing it to be a natural pain remedy.
His death certificate listed 'toxic effects of mitragynine (kratom)' as the cause.
Kratom has been used traditionally in Southeast Asia for centuries, and commercially sold in the US for decades as dried leaves or powders.
Many states have different laws about the sale of kratom, limiting it to people either 18 and up or 21 and up.
No federal age restrictions exist for 7-OH sales. Enforcement relies entirely on individual businesses. Most vendors voluntarily require ID for customers to confirm they are 18 and up or 21 and up, but this isn't mandated by law.
'We're not targeting the kratom leaf or ground-up kratom,' Makary said. 'We are targeting a concentrated synthetic byproduct that is an opioid.'
While 7-OH is naturally present in small amounts from 0.6 percent to 0.7 percent on average in kratom leaves, modern extraction techniques have made it possible to create highly concentrated products, including shots, pills, and gummies.
7-OH tablets, for example, are pre-measured dosage forms containing concentrated amounts of the compound, typically ranging from 5mg to 22mg per tablet.
An FDA-led report on 7-OH cited mounting research showing the extract acts like an opioid, hijacking the same brain receptors as morphine or prescription painkillers.
In multiple experiments, 7-OH triggered strong 'mu-opioid' effects, the same pathway targeted by drugs like oxycodone, often with 13 times the potency of morphine and nearly double the strength of kratom's primary compound, mitragynine.
When tested on cells and animal tissue, 7-OH behaved like a full opioid agonist, meaning it does not just mildly activate these receptors; it switches them on entirely, setting the stage for repeat, problem use in the future.
The FDA's report added that 7-OH's effects were reversed with the anti-overdose nasal spray naloxone.
Florida AG Uthmeier cited the FDA's findings in his decision to schedule the substance.
He said: 'We are taking emergency action now because we see immediate danger. Last week the FDA commissioner issued a warning about 7-OH, putting people on notice to the dangers, calling on states to observe and take action where necessary.
'So here in Florida, we are not going to rest on our laurels. We move fast. We want to help lead the way when it comes to public safety.'
By designating the potent kratom extracts as Schedule I drugs, the state now ranks them alongside heroin, LSD, and illegal fentanyl, deeming them equally dangerous with zero medical value.
The emergency rule grants law enforcement and regulators immediate authority to raid gas stations and smoke shops statewide, seizing the products.
Agriculture Commissioner Wilton Simpson, appearing alongside Uthmeier, told business owners to 'get it off your shelves.'
'We are going to be very aggressive,' he added.
Makary, in turn, celebrated Uthmeier's decision in 'fighting back and educating Floridian parents, law enforcement professionals, teachers and community leaders about this threat to public health.'
He added: 'I encourage other states to act now and use common sense regulation to safeguard the well-being of our youth and Make America Healthy Again.'
Florida's decision to explicitly ban 7-OH is unprecedented, though several other states, including Colorado, Mississippi, Arizona, Oklahoma, Texas, and Utah have different restrictions on the concentration of 7-OH in the products.
'I am very supportive of people seeking alternatives outside of traditional Western medicine for wellness,' Florida Surgeon General Joseph Ladapo said.
'Our problem here is not with kratom. The problem today is with 7-OH. We don't need any more substances that disconnect people from reality.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him
Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Daily Mail​

time2 hours ago

  • Daily Mail​

Phillies star Zack Wheeler begins treatment for 'scary' diagnosis that left his teammates praying for him

Philadelphia Phillies pitcher Zack Wheeler has undergone a successful thrombolysis procedure, which removed a blood clot from his upper body on Monday, the team announced. The procedure was performed by Dr. Paul DiMuzio at Thomas Jefferson University Hospital in downtown Philadelphia. Wheeler's timeline to return to the field and treatment for the procedure has yet to be determined.

CVS insurance policies don't provide opioid coverage, top Delaware court rules
CVS insurance policies don't provide opioid coverage, top Delaware court rules

Reuters

time2 hours ago

  • Reuters

CVS insurance policies don't provide opioid coverage, top Delaware court rules

Aug 18 (Reuters) - CVS Health (CVS.N), opens new tab is not entitled to coverage from insurers, including AIG (AIG.N), opens new tab and Chubb , against thousands of lawsuits over its role in the nation's opioid crisis, Delaware's highest court ruled on Monday. The Delaware Supreme Court concluded that governments, hospitals, doctors and benefit plans that sued CVS sought damages for economic losses, not individualized "bodily injury" or "property damage" covered by CVS's general liability policies. It also rejected the argument that CVS' $5 billion nationwide settlement of opioid claims in November 2022 showed that the pharmacy chain and benefits manager had been sued for bodily injury. "The national settlement agreement funds expenses in response to the opioid crisis at-large, but it does not change the fact that the underlying lawsuits do not seek specific damages tied to individualized injuries," Chief Justice Collins Seitz wrote for a unanimous court. CVS said it disagreed with the decision, and that it trains its pharmacists to make the best decisions on patients' behalf and in compliance with the law. AIG, Chubb and their lawyers did not immediately respond to requests for comment. Many insurers have been sued by pharmacy chains, drugmakers and others seeking coverage for opioid-related bills. Chains had long argued they were merely filling doctors' prescriptions, but critics said the large quantities being dispensed and the potential for diversion were red flags. Walgreens (WBA.O), opens new tab and Walmart, opens new tab(WMT.N), opens new tab agreed to pay more than $8 billion in similar settlements. CVS, based in Woonsocket, Rhode Island, had been appealing two Delaware Superior Court decisions denying insurance coverage in more than 2,300 lawsuits, according to Monday's decision. Governments complained about increased spending to treat opioid addiction, hospitals reported strains on their health systems, and third-party payors such as employee benefit funds cited costs of prescription purchases and addiction treatment. The Delaware Supreme Court ruled in Chubb's favor in a similar case involving Rite Aid in 2022. CVS claimed that its own policies offered broader coverage, but the court found the policies "similar in all material respects" to Rite Aid's. The case is In re CVS Opioid Insurance Litigation, Delaware Supreme Court, No. 482.

‘Fat jabs' for cats and dogs coming to a vet near you
‘Fat jabs' for cats and dogs coming to a vet near you

Telegraph

time3 hours ago

  • Telegraph

‘Fat jabs' for cats and dogs coming to a vet near you

Weight-loss treatments for pets are being created to help obese animals slim down. Veterinary versions of revolutionary GLP-1 drugs, such as Wegovy and Mounjaro, are being developed and tested by scientists. But while the human medicines are administered by injections once a week, the pet drugs would be delivered via implants. Early stage clinical trials in cats found that small doses of the drug exenatide, which works in a similar way to semaglutide and tirzepatide, is effective at reducing the animals' calorie intake and body weight. A study last year fitted five cats with an experimental subcutaneous implant, known as OKV-119, which released the weight loss chemical into the blood for 84 days. Analysis found four of five cats had a reduction in body mass of at least five per cent. This drug-delivery system trial is now being extended to dogs as part of a partnership between drug companies Okava and Vivani. If the trials are successful, the drugs could be available as early as 2028. 'What owners should expect to see is their pet eating appropriate portions without the previous food obsession – they'll still eat regularly and show interest in meals, just without the excessive begging, scavenging or gulping behaviour,' Michael Klotsman, the Okava chief executive, told The Guardian. He added that the medication should be viewed as an 'additional tool' rather than a first action for overweight dogs. Excess body weight can shorten lives of pets and reduce the quality of their life as well, with increased risk of cancers, arthritis, heart disease and other ailments. Some breeds are more prone to being overweight than others, with labradors among the most fat-prone of dogs. One in four labradors has a genetic fault in the POMC gene, which makes them 25 per cent slower at burning calories. The faulty POMC gene is also seen in two thirds of flat-coated retrievers, data show, and is linked to a heightened risk of obesity and being motivated by food. It is thought that around half of all cats and dogs in the UK are overweight, and scientists advise that owners worried about their pet's weight focus on regular exercise and not overfeeding. Snacks can quickly add up calorie intake and exceed a pet's recommended amount, especially in smaller pets, which need only a small amount of calories a day.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store